Skip to contentE
Endovia Health Sciences, Inc.
E
EDVAEndovia Health Sciences, Inc. Q2 2015 · 10-Q
Revenue$189.08K$189.08K+32.0% vs Q2 2014 Net Income-$15.55K-$15.55KN/M vs Q2 2014 EPS Diluted$0.00$0.00— vs Q2 2014 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Endovia Health Sciences, Inc. · CIK 1553788 · Engraved from SEC EDGAR
Operating Cash Flowderived$3,460N/M Free Cash Flowderived$194— Margins · derivedGross margin45.5%−12.9 pt vs Q2 2014
Operating margin-8.4%−6.7 pt vs Q2 2014
Net margin-8.2%−4.7 pt vs Q2 2014
ended Jun 30, 2015 · filed Oct 14, 2016 · 472 d after period end